Intravesicular localization and exocytosis of α-synuclein and its aggregates

被引:640
作者
Lee, HJ [1 ]
Patel, S [1 ]
Lee, SJ [1 ]
机构
[1] Parkinsons Inst, Sunnyvale, CA 94089 USA
关键词
synuclein; Parkinson's disease; exocytosis; protein aggregation; vesicle; neurodegeneration;
D O I
10.1523/JNEUROSCI.0692-05.2005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
alpha-Synuclein (alpha-syn), particularly in its aggregated forms, is implicated in the pathogenesis of Parkinson's disease and other related neurological disorders. However, the normal biology of alpha-syn and how it relates to the aggregation of the protein are not clearly understood. Because of the lack of the signal sequence and its predominant localization in the cytosol, alpha-syn is generally considered exclusively an intracellular protein. Contrary to this assumption, here, we show that a small percentage of newly synthesized alpha-syn is rapidly secreted from cells via unconventional, endoplasmic reticulum/Golgi- independent exocytosis. Consistent with this finding, we also demonstrate that a portion of cellular alpha-syn is present in the lumen of vesicles. Importantly, the intravesicular alpha-syn is more prone to aggregation than the cytosolic protein, and aggregated forms of alpha-syn are also secreted from cells. Furthermore, secretion of both monomeric and aggregated alpha-syn is elevated in response to proteasomal and mitochondrial dysfunction, cellular defects that are associated with Parkinson's pathogenesis. Thus, intravesicular localization and secretion are part of normal life cycle of alpha-syn and might also contribute to pathological function of this protein.
引用
收藏
页码:6016 / 6024
页数:9
相关论文
共 63 条
[1]   Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system [J].
Abeliovich, A ;
Schmitz, Y ;
Fariñas, I ;
Choi-Lundberg, D ;
Ho, WH ;
Castillo, PE ;
Shinsky, N ;
Verdugo, JMG ;
Armanini, M ;
Ryan, A ;
Hynes, M ;
Phillips, H ;
Sulzer, D ;
Rosenthal, A .
NEURON, 2000, 25 (01) :239-252
[2]   Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects [J].
Borghi, R ;
Marchese, R ;
Negro, A ;
Marinelli, L ;
Forloni, G ;
Zaccheo, D ;
Abbruzzese, G ;
Tabaton, M .
NEUROSCIENCE LETTERS, 2000, 287 (01) :65-67
[3]   A structural and functional role for 11-mer repeats in α-synuclein and other exchangeable lipid binding proteins [J].
Bussell, R ;
Eliezer, D .
JOURNAL OF MOLECULAR BIOLOGY, 2003, 329 (04) :763-778
[4]  
Cabin DE, 2002, J NEUROSCI, V22, P8797
[5]   A broken α-helix in folded α-synuclein [J].
Chandra, S ;
Chen, XC ;
Rizo, J ;
Jahn, R ;
Südhof, TC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (17) :15313-15318
[6]   α-synuclein locus duplication as a cause of familial Parkinson's disease [J].
Chartier-Harlin, MC ;
Kachergus, J ;
Roumier, C ;
Mouroux, V ;
Douay, X ;
Lincoln, S ;
Levecque, C ;
Larvor, L ;
Andrieux, J ;
Hulihan, M ;
Waucquier, N ;
Defebvre, L ;
Amouyel, P ;
Farrer, M ;
Destée, A .
LANCET, 2004, 364 (9440) :1167-1169
[7]   Mutation E46K increases phospholipid binding and assembly into filaments of human α-synuclein [J].
Choi, W ;
Zibaee, S ;
Jakes, R ;
Serpell, LC ;
Davletov, B ;
Crowther, RA ;
Goedert, M .
FEBS LETTERS, 2004, 576 (03) :363-368
[8]   The ubiquitin proteasome system in neurodegenerative diseases: Sometimes the chicken, sometimes the egg [J].
Ciechanover, A ;
Brundin, P .
NEURON, 2003, 40 (02) :427-446
[9]   Lipid droplet binding and oligomerization properties of the Parkinson's disease protein α-synuclein [J].
Cole, NB ;
Murphy, DD ;
Grider, T ;
Rueter, S ;
Brasaemle, D ;
Nussbaum, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (08) :6344-6352
[10]   Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy [J].
Conway, KA ;
Lee, SJ ;
Rochet, JC ;
Ding, TT ;
Williamson, RE ;
Lansbury, PT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) :571-576